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The involvement of miR-204 in lung cancer development is unclear. In our study, we analyzed the
expression of miR-204 in tumor- and adjacent-tissue samples from 141 patients with non-small cell
lung cancer (NSCLC). MiR-204 expression was decreased in tumor samples compared with non-
cancerous tissue-derived controls. Moreover, miR-204 expression negatively correlated with homeo-
box protein SIX1 expression, tumor size andmetastasis. MiR-204 silencing inmiR-204-positive NSCLC
cell lines promoted cell invasion and proliferation. Concomitantly, MiR-204 overexpression resulted
in reduced cell proliferation and invasion, upregulated E-cadherin and downregulated N-cadherin
and Vimentin expression. SIX1 was identiﬁed as a potential target of miR-204, and SIX1 silencing
partially compromised the invasive and proliferative capacity of miR-204-deﬁcient cells. Thus,
miR-204 may be involved in the NSCLC development.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Human lung cancer, one of the most common aggressive malig-
nancies, has the highest mortality rate in the world. According to
pathological pattern, non-small-cell lung cancer (NSCLC) is mainly
divided into squamous cell carcinoma (SCC) and adenocarcinoma
(AC) [1]. Even though there has been great improvement on tradi-
tional treatments, such as surgery, supplemented with radiother-
apy and chemotherapy, a considerable number of patients with
NSCLC are diagnosed at the advanced stages and the prognosis of
these patients is still poor. The rate of 5-year survival was very
low (approximately 10–15%) [2]. Metastasis is required for progno-
sis of patients with aggressive NSCLC [3]. Therefore, it is extremely
necessary to identify novel biomarkers used as therapeutic targets
for human NSCLC.
microRNA is a class of small, well-conserved, non-coding RNAs,
and could regulate the biology processes of different diseases and
play a potential role as diagnostic and prognostic biomarkers of
cancers [4–6]. The mature miRNAs are single-stranded RNAsapproximately 22 nucleotides in length. Recent studies reported
that down-regulation of miRNA-204 by LMP-1 enhances CDC42
activity and facilitates invasion of EBV-associated nasopharyngeal
carcinoma cells [7]. miR-204 plays an important role in regulating
metastasisof gastric cancer,which is involved in post-transcriptional
repression of SIRT1 [8]. However, the underlying mechanism of
miR-204 and the development of NSCLC were not mentioned.
In vertebrates, the SIX family is classiﬁed into three subgroups,
SIX1/SIX2 (So), SIX3/SIX6 (Optix), and SIX4/SIX5 (Dsix4), which are
characterized by a SIX-type homeodomain (HD, 60 amino acids)
and SIX-domain (SD, 110–115 amino acids) [9]. Among these,
SIX1, the most extensively investigated, is involved in the develop-
ment of many tissues and organs, such as muscle [10], kidney [11],
and craniofacial structures [12]. So far, much attention has been
paid to the role of SIX1 in tumorigenesis. Numerous studies have
documented that SIX1 participates in the occurrence of various
human cancers including breast cancer [13], ovarian cancer [14],
cervical cancer [15], hepatocellular carcinoma [16] and colorectal
cancer [17].
In our study, we sought to investigate the crucial role of miR-
204 in NSCLC and found that miR-204 was related to tumor size
and metastasis. Moreover, we identiﬁed that miR-204 could
regulate the invasion and proliferation of NSCLC, which is involved
in post-transcriptional repression of SIX1.
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2.1. Tissue samples
Total lung cancer samples and the corresponding adjacent tis-
sues were collected from the 141 patients that had undergone rou-
tine surgery at The First Afﬁliated Hospital of Nanjing Medical
University from May 2010 and June 2013. All tissues were imme-
diately snapped frozen in liquid nitrogen, and stored at 80 C
until RNA extraction. This study was approved by the Ethical
Committee of The First Afﬁliated Hospital of Nanjing Medical
University, and every patient had written informed consent.
2.2. DNA and RNA preparation
Total RNA was extracted from tissue specimens using the TRIzol
method (Invitrogen, Shanghai, China) and cDNA was synthesized
using reverse transcriptase kit (TAKARA, Tokyo, Japan) according
to the manufacturers’ protocol.
2.3. Real-time polymerase chain reaction for miR-204 and SIX1 RNA
expression
The expression levels of miRNAs were analyzed by the TaqMan
stem-loop qRT-PCR method with a mirVana miRNA Detection Kit
and gene-speciﬁc primers. U6 small nuclear RNA was used for nor-
malization. Relative expression levels of SIX1 mRNA were assessed
by SYBR Green quantitative real-time PCR (qRT-PCR) and normal-
ized to GAPDH. Primers of SIX1 for qRT-PCR were as follows:
forward, 50-AAGGAGAAGTCGAGGGGTGT-30; reverse 50-TGCTTGTT
GGAGGAGGAGTT-30. Primers of GAPDH were as follows: forward,
50-GGAGCGAGATCCCTCCAAAAT-30 and reverse, 50-GGCTGTTGTCAT
ACTTCTCATGG-30. qRT-PCR was performed by using the ABI 7900
Fast Real-Time PCR system (ABI, CA, USA).
2.4. Cell culture
The lung cancer cell lines (A549, H1299, SPCA1, H1650 and
H358) and normal lung cell (BEAS-2B) used in this study were pur-
chased from the Institute of Biochemistry and Cell Biology of the
Chinese Academy of Sciences (Shanghai, China). All cell lines were
cultured in RPMI-1640 medium (Gibco, USA) with 10% fetal bovine
serum (Invitrogen, Carlsbad, CA) and penicillin (100 U/ml). Cells
were cultured at 37 C with 5% CO2.
2.5. Transient transfection
Oligonucleotides NC (miR-control), miR-204 mimics (hsa-miR-
204 mimics), inhibitor NC (anti-miR-control), hsa-miR-204 inhibi-
tor (anti-miR-204) were purchased from GenePharma (Shanghai,
PR China). Cells were seeded into 6-well plates and transfected
with 50 nM siRNA/SIX1 and siRNA/control (GenePharma, Shanghai,
China) using Lipofectamine 2000 (Invitrogen, USA) according to the
instructions provided by the manufacturer. Transfection of cells
with oligonucleotides was performed using Lipofectamine 2000
Reagent (Invitrogen, Carlsbad, CA, USA) at a ﬁnal concentration of
100 nM. Transfection efﬁciency was monitored by qRT-PCR.
2.6. Transwell invasion assay
Invasion assays were performed with BioCoat Matrigel (BD Bio-
sciences, San Jose, CA) and invasion chambers (Millipore, Eschborn,
Germany) with an 8-lm pore size according to the manufacturer’s
instructions. The chamber inserts were coated with 200 mg/ml BD
Matrigel (BD Biosciences, San Jose, CA, USA) and dried overnight.Cell lines (5  104) were incubated at 37 C for 48 h and were
stained with crystal violet. A set of images was acquired using
NIS Elements image analysis software (Nikon, Tokyo, Japan). The
values for invasion were obtained by counting three ﬁelds per
membrane and represented the average of three independent
experiments.
2.7. Cell-proliferation assay (cell-counting kit-8)
Cells were seeded into 96-well plates (6.0  103 cells per well).
Cell viability was assessed by cell-counting kit-8 assay (Beyotime
Institute of Biotechnology, Shanghai, China). The absorbance of
each well was read on a spectrophotometer (Thermo) at 450 nm
(A450). Three independent experiments were performed in
quintuplicate.
2.8. Apoptosis assay
Twenty-four hours after transfection, apoptosis in cultured cells
was evaluated using annexin V labeling. An annexin V-APC labeled
Apoptosis Detection Kit (Abcam) was used according to the manu-
facturer’s protocol.
2.9. Western blot
Proteins were extracted from cultured cells, quantitated using
a protein assay (bicinchoninic acid [BCA] method; Beyotime,
Shanghai, China). Proteins were fractionated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis, transferred to polyvi-
nylidene ﬂuoride (PVDF) membrane, blocked in 4% dry milk at
room temperature for 1 h, and immunostained with primary
antibodies at 4 C overnight using anti-SIX1 (1:1000, Abcam,
Cambridge, United Kingdom), anti-E-cadherin, anti-N-cadherin,
anti-Vimentin (1:1000, Dizhao, Nanjing, China) and GAPDH
(1:5000; Abcam, Cambridge, United Kingdom). The results were
visualized via a chemiluminescent detection system (Pierce ECL
Substrate Western blot detection system; Thermo, Rockford, IL)
and exposed in Molecular Imager ChemiDoc XRS System
(Bio-Rad, Hercules, CA).
2.10. Plasmid construction and cell transduction
30-UTR sequence of SIX1 which was predicted to interact with
miR-204 or a mutant sequence with the predicted target sites
was inserted into the KpnI and SacI sites of pGL3 promoter vector
(Genscript, Nanjing, China). They were named pGL3-SIX1 and
pGL3-SIX1-mut. The cells were plated onto 6-well plates and were
transfected with 100 ng of pGL3-SIX1 or pGL3-SIX1-mut, and
miR-204 mimics (50 nM) by using Lipofectamine 2000 (Invitrogen
Corp, CA, USA). SIX1 gene was synthesized (purchased from Gen-
script, Piscataway, NJ) with restrictive digestion using Mlu I and
subcloned pLV-GFP plasmid (gift from D. Beicheng Sun, University
of Nanjing Medical University, China), and named pLV-GFP–SIX1.
Recombinant lentivirus was generated from 293T cells using
calcium phosphate precipitation. Cell lines were transfected with
lentivirus using polybrene (8 lg/ml).
2.11. Bioinformatics analysis
The bioinformatics method was used to predict the potential
targeting genes of miR-204. According to the results shown in the
microRNA.org (http://www.microrna.org/microrna/), miRDB (http:
//mirdb.org/cgi-bin/), and TargetScan (http://www.targetscan.org/
) database, SIX1 was the candidate gene. The result from bioinfor-
matic software indicated that 30-UTR of SIX1 binds to miR-204 with
the high score.
Table 1
Correlation between miR-204 (or SIX1) Status and Clinical Characteristics in patients with NSCLC.
Characteristics All
patients
miR-204 low
expression
(6mediana)
miR-204 high
expression
(>mediana)
p Value SIX1 low expression
(<medianb)
SIX1 high expression
(Pmedianb)
p Value
No. 141 71 70 70 71
Age (years) 0.937 0.677
<60 66 33 33 34 32
P60 75 38 37 36 39
Gender 0.450 0.935
Male 73 39 34 36 37
Female 68 32 36 34 34
Histology 0.672 0.931
AC 72 35 37 36 36
SCC 69 36 33 34 35
Tumor size 0.008* 0.003*
T1/T2 55 20 35 36 19
T3/T4 86 51 35 34 52
Tumor stage <0.000* <0.000*
I-II 56 18 38 39 17
III-IV 85 53 32 31 54
Metastasis <0.000* <0.000*
Yes 40 31 9 10 30
No 101 40 60 60 40
AC: adenocarcinoma; SCC: squamous cell carcinoma; NSCLC: non-small-cell lung cancer.
⁄ Indicates p value < 0.05.
a Median = 0.4051.
b Median = 3.0015.
Fig. 1. miR-204 is reduced and SIX1 is elevated in NSCLC patients. (A) miR-204 mRNA expression in NSCLC patients (n = 141) and corresponding adjacent tissues (n = 141)
relative to U6 detected by using qRT-PCR (P < 0.05). T refers to tumor tissues and P refers to corresponding adjacent tissues. (B) The mRNA expression level of SIX1 relative to
GAPDH in human NSCLC tissues and corresponding adjacent tissues were also investigated by using qRT-PCR. T refers to tumor tissues and P refers to corresponding adjacent
tissues. (C) A negative correlation was found between RNA expression of miR-204 and SIX1 in tumor samples (R = 0.797; P < 0.0001). (D) Expression of miR-204 was
analyzed in ﬁve lung cancer cell lines (A549, H1299, SPCA1, H1650 and H358) and normal lung cell (BEAS-2B). Data are represented as mean ± S.E.M. ⁄Indicates P < 0.05.
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Fig. 2. miR-204 regulates the invasive ability of NSCLC cell lines in vitro. (A) The results of miR-204 expression in cell lines transfected with miR-204 mimics, miR-204
inhibitor, control for miR-mimics (NC) and control for miR-204 inhibitor (inhibitor NC) were validated by using qRT-PCR. (B) Transwell assay was performed according to the
Section 2. A549 and SPCA1 were treated with miR-204 mimics, miR-204 inhibitor, NC and inhibitor NC for 24 h. The representative images of invasive cells at the bottom of
the membrane stained with crystal violet were visualized as shown. The quantiﬁcations of cell invasion were presented as percentage of cell numbers. All experiments were
performed in triplicate and presented as mean ± S.E.M. ⁄Indicates signiﬁcant difference compared with control group (P < 0.05). Every independent experiment was
performed three times.
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Fig. 3. miR-204 inhibits cell proliferation but has no effect on cell apoptosis in vitro. (A) The cell-proliferation assay test showed distinct differences on proliferation after
manipulation of miR-204 in both A549 and SPCA1 cells at 12-h, 24-h, and 48-h time points. A549 (left) and SPCA1 (right). (B) Flow cytometry assay was performed to assess
cell apoptosis. A549 (left) and SPCA1 (right) ⁄indicates signiﬁcant difference compared with control group (P < 0.05).
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The luciferase reporter assay were measured in Victor 1420
Multilabel Counter (Wallac, Finland) using Luciferase Assay System
(Promega, USA) according to the manufacturer’s protocol, when
cell lines were transfected about 48 h.
2.13. Statistical methods
The statistical analysis was performed using STAT11 and
GraphPad Prism (version 5.01; GraphPad Software, Inc., La Jolla,
CA) statistical software. The chi-squared test was used to test the
signiﬁcance of observed differences in the Table 1 data and the
t-test was used for the other data analyses. The signiﬁcance was
accepted as p value was less than 0.05.
3. Results
3.1. miR-204 expression is reduced and negatively correlates with SIX1
expression in human lung cancer tissues
To investigate the role of miR-204 in human NSCLC, we ﬁrst
searched the expression of miR-204 in NSCLC patient samples
and corresponding adjacent tissues. Analysis using qRT-PCR
showed that miR-204 was signiﬁcantly decreased in NSCLC sam-
ples (n = 141) (Fig. 1A). Meanwhile, we also discovered that SIX1was overexpressed in NSCLC samples by using qRT-PCR (Fig. 1B).
Patients were divided into two groups based on their miR-204
expression levels: those with less than or equal to median of
miR-204 expression levels and those with more than median of
miR-204 expression levels (median: 0.4051), those with less than
median of SIX1 expression levels and those with more than or
equal to median of SIX1 expression levels (median: 3.0015). The
median was used as cut off. Moreover, an inverse correlation was
observed between miR-204 and SIX1 (R = 0.797; P < 0.0001;
Fig. 1C) in cancer samples. Furthermore, the relationship between
miR-204 (SIX1) expression levels and clinicopathological charac-
teristics were showed in Table 1. Age, gender and histology were
not associated with the expression of miR-204 or SIX1. However,
tumor size (P < 0.05) and higher metastasis rate (P < 0.01) were
observed signiﬁcantly in both low-miR-204 and high-SIX1 expres-
sion groups, which supported the result of correlation analysis,
suggesting a potential functional link of miR-204 and SIX1. All
these results indicated that miR-204 (SIX1) might be involved in
the metastasis of patients with NSCLC.
3.2. miR-204 regulates the invasive ability of NSCLC cell lines in vitro
To explore the role of miR-204 expression in NSCLC tumorigen-
esis, we detected the effect of miR-204 overexpression and inhibi-
tion on cell lines invasion by using a transwell invasion assay. In
our study, the expression of miR-204 was examined in ﬁve lung
Fig. 4. miR-204 regulates SIX1 expression by directly binding its 30-UTR. (A) the potential miR-204 seed region at the 30-UTR of SIX1 mRNA was computationally predicted by
using TargetScan. A549 cells were co-transfected with miR-204 mimics (or NC) with pGL3-SIX1 (or pGL3-SIX1-MUT) vector. Luciferase activity was normalized by the ratio of
ﬁreﬂy and Renilla luciferase signals. (B) SIX1 mRNA and protein expression levels in A549 and SPCA1 cells transfected with NC, miR-204 mimics, inhibitor NC and miR-204
inhibitor were analyzed by using qRT-PCR Western-blotting assay. GAPDH was used as a control. All experiments were performed in triplicate and the band intensity values
were analyzed by using Image J. Then, the signiﬁcance in change in protein expression was analyzed by using statistical t-tests. Data are represented as mean ± S.E.M.
⁄Indicates P < 0.05.
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normal lung cell line (BEAS-2B) by using qRT-PCR. As shown in
Fig. 1D, the expression of miR-204 was substantially reduced in
all ﬁve cell lines derived from lung cancer, compared with the
normal BEAS-2B cell line. And the expression of miR-204 in
A549 and SPCA1 was between those in H1650 and in H358
(H1299). According to this expression pattern, the A549 and
SPCA1 lung cancer cell lines were chosen to investigate the effect
of miR-204. Therefore, A549 and SPCA1 cell lines were transfected
with NC (mimics negative control), miR-204 mimics, inhibitor NC
and miR-204 inhibitor respectively. The transfection efﬁciency
was validated by using qRT-PCR (Fig. 2A). The invasion assay
showed that overexpression of miR-204 signiﬁcantly inhibited cell
lines invasion, whereas downregulation of miR-204 expression
promoted the invasive ability of NSCLC cell lines (Fig. 2B). These
ﬁnding demonstrated that miR-204 could inhibit the invasive
ability of NSCLC cell lines in vitro.
3.3. miR-204 inhibits cell proliferation
Next, to examine whether miR-204 could regulate NSCLC cell
lines proliferation in vitro, the effect of miR-204 on proliferation
was detected by using CCK8 assay. The cell-proliferation assay test
showed distinct differences on proliferation after manipulation of
miR-204 in both A549 and SPCA1 cells at 12-h, 24-h, and 48-h time
points. The assay showed that miR-204 overexpression or down-
regulation could affect cell proliferation (Fig. 3A). Furthermore,
we also performed an apoptosis assay to investigate whether aber-
rant expression of miR-204 could control NSCLC cell lines apopto-
sis. However, as shown in Fig. 3B, there was no signiﬁcantdifference. Collectively, the data suggested that miR-204 could
inhibit A549 and SPCA1 cell lines proliferation in vitro.
3.4. miR-204 regulates SIX1 expression by directly binding its 30-UTR
To search insights into the biological implications of miR-204 on
lung cancer tumorigenesis, we performed a bioinformatics analysis.
Based on bioinformatics analysis, microRNA.org (http://www.
microrna.org/microrna/), miRDB (http://mirdb.org/cgi-bin/), and
TargetScan (http://www.targetscan.org/) database, bioinformatic
software indicated that 30-UTR (untranslated region) of SIX1 binds
tomiR-204 with the high score (mirSVR score:1.1501). According
to the results of prediction, the 30-UTR fragment containing the
predicted site was cloned into pGL3 luciferase reporter vector
(pGL3-SIX1) to further determine the relationship between
miR-204 and SIX1 expression. The 30-UTR fragment with mutant
sequence was also cloned as a control group (pGL3-SIX1-MUT) in
the predicted target site. The luciferase activity decreased in A549
cells with miR-204 mimics and pGL3-SIX1 vectors. However,
miR-204mimics did not have any effect on luciferase activity when
target cells were transfected with pGL3-SIX1-MUT vector (Fig. 4A).
The results indicated that SIX1 gene was one of the direct targets of
miR-204.
In additional, to conﬁrm the regulatory effect of miR-204 on
SIX1, we performed Western blot assay to detect the expression
of SIX1 responses to the changes of miR-204 expression both in
A549 and SPCA1 cell lines. As shown in Fig. 4B, the assay showed
a negative regulatory effect of miR-204 on SIX1. Up-regulated
miR-204 could decrease the expression of SIX1; meanwhile,
down-regulated miR-204 could increase SIX1 expression level.
Fig. 5. Expression of SIX1 abrogates the anti-invasion functions of miR-204. (A) Both A549 and SPCA1 cells were co-transfected with miR-204 inhibitor and siRNA/SIX1. The
transfection cells of miR-204 inhibitor and the co-transfection cells of miR-204 inhibitor and siRNA/control were regarded as the control groups. The transfection efﬁciency
was conﬁrmed by using qRT-PCR and Western blot assays. (B) Transwell assay was performed according to the Section 2. The representative images of invasive cells at the
bottom of the membrane stained with crystal violet were visualized as shown. The quantiﬁcations of cell invasion were presented as percentage of cell numbers. ⁄Indicates
P < 0.05.
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Fig. 6. Silencing of SIX1 reverses the effect of miR-204 downregulated and miR-204 regulates EMT. (A) The cell-proliferation assay test showed distinct differences on
proliferation after both A549 and SPCA1 cells transfected with miR-204 inhibitor and inhibitor + siRNA/SIX1 (the co-transfection cells of miR-204 inhibitor and siRNA/SIX1)
and inhibitor + siRNA/control (co-transfected with miR-204 inhibitor and siRNA/control) at 12-h, 24-h, and 48-h time points. A549 (left) and SPCA1 (right). (B) E-cadherin, N-
cadherin and Vimentin protein expression levels in A549 and SPCA1 cells transfected with NC, miR-204 mimics, inhibitor NC, and miR-204 inhibitor were analyzed by using
Western-blotting. GAPDH was used as a control. Average values of integrated optical density (IOD) were assessed by analyzing ﬁve ﬁelds per slide and recorded in the
histogram. ⁄Indicates P < 0.05.
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control SIX1 expression by directly binding its 30-UTR in vitro.
3.5. Silencing of SIX1 by siRNA partially reverses the effect of miR-204
downregulated
In the past two decades, many studies have shown that SIX1 is a
powerful regulator of organogenesis and disease, with important
roles in tumorigenesis [17,18]. In our study, to further test whether
the functional effect of miR-204 on NSCLC cell lines was exerted via
SIX1, we performed a rescue experiment. As shown above, SIX1
was increased in cells which were transfected with miR-204 inhib-
itor. Thus, we silenced the expression of SIX1 by RNA interference.
Both A549 and SPCA1 cells were co-transfected with miR-204
inhibitor and siRNA/SIX1. The transfection cells of miR-204 inhib-
itor and the co-transfection cells of miR-204 inhibitor and siRNA/
control were serve as the control groups. The transfection efﬁ-
ciency was conﬁrmed by using qRT-PCR and Western blot assays
(Fig. 5A). Compared with the control groups, the expression level
of SIX1 was obviously reduced both in cells co-transfected with
miR-204 inhibitor and siRNA/SIX1. Then, the transwell invasion
assay as shown in Fig. 5B also showed that the invasive ability
indeed reversed to some extent when silenced SIX1 in cells trans-
fected with miR-204 inhibitor compared to control. Furthermore,
the CCK8 assay showed that silencing of SIX1 by RNA interference
(siRNA) partially abolished the enhancement of cells proliferation
induced by down-regulated miR-204 (Fig. 6A). Taken together,
these results suggested that the functional effect of miR-204 on
NSCLC cell lines was dependent on SIX1.
3.6. Ectopic low-expression of miR-204 induces epithelial-to-
mesenchymal transition (EMT)
Metastasis is a complex, multi-step and dynamic biological
event, and a critical process in the metastatic cascade is the epithe-
lial-to-mesenchymal transition (EMT). Epithelial-to-mesenchymal
transition (EMT) has been identiﬁed as a key role in the invasion
of various cancer cells by the transformation of polarized and
adherent epithelial cells into motile and invasive mesenchymal
cells. To determine if molecular changes typical of EMT occurred
in cell lines, the expression of mesenchymal markers, including
N-cadherin and Vimentin and the epithelial marker, E-cadherin,
was examined in the A549 and SPCA1 cell lines by Western blot.
Thus, cell lines were transfected with NC, miR-204 mimics, inhibi-
tor NC and miR-204 inhibitor. In the protein expression level,
upregulated miR-204 expression resulted in evaluated E-cadherin
expression and decreased N-cadherin and Vimentin expression.
Meanwhile, suppressed miR-204 expression resulted in decreased
E-cadherin expression and increased N-cadherin and Vimentin
expression (Fig. 6B). This ﬁnding indicated thatmiR-204might con-
tribute to regulating EMT marker expression in NSCLC in vitro.
4. Discussion
Lung cancer is one of the common causes of cancer-related
death in the world. The major causes of death from cancer are com-
plications arising from metastasis [19]. Metastasis are character-
ized by the ability of cancer cells to invade into adjacent area,
intravasate into blood or lymphatic vessels, and extravasate into
a distant environment. Recently, several non-coding regulatory
RNA genes, microRNA (miRNA) were identiﬁed, which play roles
in various steps of metastasis. The exploration of the mechanisms
of metastasis is crucial for improving surgery and treatment
outcome.microRNAs (miRNAs) have been reported to be upregulated or
downregulated in disease states and speciﬁc cell types. Recently,
miRNAs have gained recognition as major regulators of human
gene expression, accounting for their important role in the differ-
ent cancers. miRNAs indirectly regulate the target genes by binding
their 30-UTR. Accumulating evidence reveals the crucial role of
miRNAs in NSCLC proliferation, invasion, prognosis and other biol-
ogy processes. For example, Lei et al. identiﬁed the oncogenic func-
tion of miR-92b in NSCLC through targeting reversion-inducing-
cysteine-rich protein with kazal motifs (RECK) [20]. Zhang et al.
reported that miR-150 promoted the proliferation of NSCLC cells
by targeting p53 [21]. In contrast, miR-638 [22] and miR-625
[23] acted as tumor suppressors via targeting SRY (sex determining
region Y)-box 2 (SOX2), respectively. The concept of miRNAs as
powerful regulators of EMT has transformed the conventional nar-
rative of carcinoma progression, and several miRNAs have now
been described as crucial EMT regulators.
In our study, the expression of miR-204 was lower in NSCLC tis-
sues than in corresponding adjacent areas. And downregulation of
miR-204 promoted the invasion and proliferation of NSCLC cell
lines, while the effect of miR-204 overexpression was reverse. Fur-
thermore, we also discovered that miR-204 overexpression dimin-
ished but miR-204 knockdown increased SIX1 expression level in
A549 and SPCA1 cell lines by directly binding the 30-UTR of SIX1.
Upregulated miR-204 expression resulted in evaluated E-cadherin
expression and decreased N-cadherin and Vimentin expression.
Meanwhile, suppressed miR-204 expression resulted in decreased
E-cadherin expression and increased N-cadherin and Vimentin
expression. This ﬁnding indicated that miR-204 might contribute
to regulating EMT marker expression. Similarly, we tried to eluci-
date the reverse regulation of miR-204 and SIX1 within limits of
NSCLC, but we are unsure whether miR-204 has other targets
related to NSCLC proliferation and invasion. It is well-known that
the changes in the development of NSCLC should not be attributed
to alternations of one or a small quantity of genes. Thus, it is nec-
essary for further exploration of the potential role of miR-204 in
the development of NSCLC.
SIX1 belongs to the homeodomain (HD) of the SIX families.
Homeobox domain genes were ﬁrst discovered in Drosophila and
are a class of highly conserved protein with a HD of 61 amino acids,
which can bind to target genes, thus activating or inhibiting down-
stream genes, participating in embryonic development, gene tran-
scription, cell differentiation, and neurogenesis [24]. Prior reports
demonstrated that aberrant SIX1 expression is related to develop-
ment, progression, and prognosis of multiple tumors. Overexpres-
sion of SIX1 upregulates cyclin D1 mRNA and protein, and
signiﬁcantly enhances the activity of the cyclin D1 promoter in pan-
creatic cancer cells [18]. Yu et al. reported that SIX1 is able to acti-
vate the expression of a set of protumorigenic genes (encoding
cyclin D1, c-Myc, and Ezrin) that can control cell proliferation, sur-
vival, and motility. The gene encoding Ezrin is a direct transcrip-
tional target of Six1 [25]. Induction of epithelial–mesenchymal
transition is considered to be involved inmigration, tumor invasion,
and dissemination. Recently, Li et al. reported that SIX1 overexpres-
sion promotes EMT, CSCs properties and malignant conversion in
HKc/DR through MAPK activation [26]. Here, we found that SIX1
was increased in NSCLC tissues and was associated with tumor size
and metastasis. Furthermore, we discovered that silencing of SIX1
by siRNA partially abolished the enhancement of cells invasion
and proliferation induced by down-regulated miR-204.
In conclusion, our ﬁndings showed that miR-204 was down-
regulated, while SIX1 was up-regulated in NSCLC tissues. Ectopic
miR-204 expression regulated the expression level of SIX1 in the
cell lines (A549 and SPCA1). We also identiﬁed that miR-204
3712 Y. Xia et al. / FEBS Letters 588 (2014) 3703–3712inhibited lung cancer invasion and proliferation via repression of
SIX1. Moreover, aberrant miR-204 expression regulated epithe-
lial-to-mesenchymal transition (EMT). In future, miR-204-SIX1
pathway that we studied might be exploited in a therapeutic
approach for the treatment of lung cancers.
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